TALPHERA, INC. Proceeds from Issuance of Private Placement
TALPHERA, INC. (TLPH) had Proceeds from Issuance of Private Placement of $10.00 million as of 2023-07-17, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-03-31
- TALPHERA, INC. proceeds from issuance of private placement for the quarter ending 2012-09-30 was $5.00K.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 84 month | Proceeds from Issuance of Private Placement 87 month |
|---|---|---|---|---|---|---|
| 2023-07-17 | $10.00M 10-K · filed 2025-03-31 | |||||
| 2012-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $9.08M 10-Q · filed 2012-11-06 | $9.08M 10-Q · filed 2012-11-06 | |||
| 2012-06-30 | $9.07M 10-Q · filed 2012-08-10 | $9.07M 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |